Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Breast 1

Conditions

Myelodysplastic Syndromes 17Leukemia, Myeloid, Acute 13Leukemia 10Anemia, Refractory, with Excess of Blasts 6Leukemia, Myelomonocytic, Chronic 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Congenital Abnormalities 3Blast Crisis 3Lymphoma 2Leukemia, Biphenotypic, Acute 2Neutropenia 1Myelodysplastic-Myeloproliferative Diseases 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Drug-Related Side Effects and Adverse Reactions 1Down Syndrome 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1Burkitt Lymphoma 1

Interventions

Amifostine 2sargramostim 1Mitoxantrone 1Epoetin Alfa 1Cytarabine 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Mitoxantrone × Myeloid × Clear all
NCT00003407 2023-02-02

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Rush University Medical Center

Phase 2 Withdrawn
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Acute, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡